Case Report

Published on 09 Aug 2022

Anti-PD-1 sintilimab-induced bilateral optic neuropathy in non-small cell lung cancer: A case report and literature review

in Thoracic Oncology

Jian Wang
Xiaoyue Xiao
Xiaorong Dong
Gang Wu
Xinghua Wang
Ruiguang Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.931074

2,630 views
1 citation

Case Report

Published on 09 Aug 2022

Successful treatment with docetaxel plus nintedanib in a patient with lung adenocarcinoma and pulmonary fibrosis: A case report and literature review

in Thoracic Oncology

Tanya Zlatanova
Jeliazko Arabadjiev
Galina Kirova-Nedyalkova
Diana Nikova

Frontiers in Oncology

doi 10.3389/fonc.2022.907321

2,454 views
2 citations

Original Research

Published on 08 Aug 2022

Cuproptosis predicts the risk and clinical outcomes of lung adenocarcinoma

in Thoracic Oncology

Qin Hu
Runtian Wang
Huiyun Ma
Zhouwei Zhang
Qun Xue

Frontiers in Oncology

doi 10.3389/fonc.2022.922332

9,579 views
38 citations

Case Report

Published on 08 Aug 2022

Case report: Major pathologic response induced by neoadjuvant treatment using BRAF and MEK inhibitors in a patient with stage IIIA lung adenocarcinoma harboring BRAF V600E-mutation

in Thoracic Oncology

Chaoyuan Liu
Min Lu
Yang Yang
Xiang Wang
Fang Ma
Xianling Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.961539

1,914 views
5 citations

Perspective

Published on 08 Aug 2022

The quantum leap in therapeutics for advanced ALK+ non-small cell lung cancer and pursuit to cure with precision medicine

in Thoracic Oncology

Malinda Itchins
Nick Pavlakis

Frontiers in Oncology

doi 10.3389/fonc.2022.959637

6,476 views
1 citation

Original Research

Published on 08 Aug 2022

Comparison of hook-wire and medical glue for CT-guided preoperative localization of pulmonary nodules

in Thoracic Oncology

Huijun Zhang
Ying Li
Xiaofeng Chen
Zelai He

Frontiers in Oncology

doi 10.3389/fonc.2022.922573

1,705 views
14 citations

Original Research

Published on 05 Aug 2022

PD-L1 expression, tumor mutational burden, and immune cell infiltration in non-small cell lung cancer patients with epithelial growth factor receptor mutations

in Thoracic Oncology

Tiantian Ma
Jin Jiao
Ran Huo
Xiaofang Li
Guotao Fang
Qi Zhao
Weiwei Liu
Xiao Han
Chenglin Xi
Yanan Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.922899

3,046 views
12 citations

Case Report

Published on 04 Aug 2022

Case report: Mesothelioma and BAP1 tumor predisposition syndrome: Implications for public health

in Thoracic Oncology

Luigi Vimercati
Domenica Cavone
Francesco Fortarezza
Maria Celeste Delfino
Romina Ficarella
Angela Gentile
Angela De Palma
Giuseppe Marulli
Luigi De Maria
Concetta Caporusso

Frontiers in Oncology

doi 10.3389/fonc.2022.966063

6,072 views
4 citations

Original Research

Published on 04 Aug 2022

Robotic-assisted thoracic surgery following neoadjuvant chemoimmunotherapy in patients with stage III non-small cell lung cancer: A real-world prospective cohort study

in Thoracic Oncology

Yang Gao
Juan Jiang
Desheng Xiao
Yanwu Zhou
Yufan Chen
Huaping Yang
Lijing Wang
Jun Zeng
Baimei He
Ruoxi He

Frontiers in Oncology

doi 10.3389/fonc.2022.969545

3,490 views
14 citations

Original Research

Published on 03 Aug 2022

Reduction of inter-observer variability using MRI and CT fusion in delineating of primary tumor for radiotherapy in lung cancer with atelectasis

in Thoracic Oncology

Hongjiao Zhang
Chengrui Fu
Min Fan
Liyong Lu
Yiru Chen
Chengxin Liu
Hongfu Sun
Qian Zhao
Dan Han
Baosheng Li

Frontiers in Oncology

doi 10.3389/fonc.2022.841771

1,933 views
5 citations

Original Research

Published on 03 Aug 2022

Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC

in Thoracic Oncology

Rachel Evans
Kelvin Lee
Paul K. Wallace
Mary Reid
Jason Muhitch
Askia Dozier
Circe Mesa
Patricia L. Luaces
Orestes Santos-Morales
Adrienne Groman

Frontiers in Oncology

doi 10.3389/fonc.2022.958043

4,507 views
4 citations

Original Research

Published on 02 Aug 2022

A novel defined m7G regulator signature to investigate the association between molecular characterization and clinical significance in lung adenocarcinoma

in Thoracic Oncology

Yi Dong
Yingge Li
Yi Yao
Qibin Song

Frontiers in Oncology

doi 10.3389/fonc.2022.897323

3,154 views
6 citations

Correction

Published on 02 Aug 2022

Corrigendum: Successful treatment of a patient with multiple-line relapsed extensive-stage small-cell lung cancer receiving penpulimab combined with anlotinib: A case report

in Thoracic Oncology

Zibo Zhang
Yujun Li
Yan Dong
Jia Li
Bin Zhang
Chunxia Zhang
Xiaonan Cui

Frontiers in Oncology

doi 10.3389/fonc.2022.980842

1,327 views

Original Research

Published on 02 Aug 2022

Id2 exerts tumor suppressor properties in lung cancer through its effects on cancer cell invasion and migration

in Thoracic Oncology

Jian-Ting Chen
Yuan-Ling Hsu
Yi-Chiung Hsu
Yi-Hsin Tseng
Ming-Han Liu
Chia-Wei Weng
Ching-Hao Lin
Szu-Hua Pan
Jeremy J.W. Chen
Chi-Chung Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.801300

2,516 views
8 citations

Review

Published on 02 Aug 2022

Immunotherapy in non-small cell lung cancer: Past, present, and future directions

in Thoracic Oncology

Salman R. Punekar
Elaine Shum
Cassandra Mia Grello
Sally C. Lau
Vamsidhar Velcheti

Frontiers in Oncology

doi 10.3389/fonc.2022.877594

13,988 views
45 citations

Systematic Review

Published on 01 Aug 2022

An updated network meta-analysis of EGFR-TKIs and combination therapy in the first-line treatment of advanced EGFR mutation positive non-small cell lung cancer

in Thoracic Oncology

Yuexiao Qi
Xiaojun Xia
Lihua Shao
Liyun Guo
Yumei Dong
Jinhui Tian
Lijun Xu
Ruijun Niu
Shihong Wei

Frontiers in Oncology

doi 10.3389/fonc.2022.616546

4,615 views
5 citations

Navigation group

Articles

Anti-PD-1 sintilimab-induced bilateral optic neuropathy in non-small cell lung cancer: A case report and literature review

Successful treatment with docetaxel plus nintedanib in a patient with lung adenocarcinoma and pulmonary fibrosis: A case report and literature review

Cuproptosis predicts the risk and clinical outcomes of lung adenocarcinoma

Case report: Major pathologic response induced by neoadjuvant treatment using BRAF and MEK inhibitors in a patient with stage IIIA lung adenocarcinoma harboring BRAF V600E-mutation

The quantum leap in therapeutics for advanced ALK+ non-small cell lung cancer and pursuit to cure with precision medicine

Comparison of hook-wire and medical glue for CT-guided preoperative localization of pulmonary nodules

PD-L1 expression, tumor mutational burden, and immune cell infiltration in non-small cell lung cancer patients with epithelial growth factor receptor mutations

Case report: Mesothelioma and BAP1 tumor predisposition syndrome: Implications for public health

Robotic-assisted thoracic surgery following neoadjuvant chemoimmunotherapy in patients with stage III non-small cell lung cancer: A real-world prospective cohort study

Reduction of inter-observer variability using MRI and CT fusion in delineating of primary tumor for radiotherapy in lung cancer with atelectasis

Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC

A novel defined m7G regulator signature to investigate the association between molecular characterization and clinical significance in lung adenocarcinoma

Corrigendum: Successful treatment of a patient with multiple-line relapsed extensive-stage small-cell lung cancer receiving penpulimab combined with anlotinib: A case report

Id2 exerts tumor suppressor properties in lung cancer through its effects on cancer cell invasion and migration

Immunotherapy in non-small cell lung cancer: Past, present, and future directions

An updated network meta-analysis of EGFR-TKIs and combination therapy in the first-line treatment of advanced EGFR mutation positive non-small cell lung cancer